Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 11, 2023

Primary Completion Date

December 15, 2025

Study Completion Date

December 15, 2025

Conditions
Brain Injuries, Traumatic
Interventions
DRUG

Cannabidiol

The current study will directly test the hypothesis that a moderate dose of CBD leads to improvements in cognition, TBI-related symptoms, pain, sleep, depression, anxiety, and peripheral markers of inflammation and oxidative stress.

DRUG

Placebo

Placebo arm

Trial Locations (1)

80045

RECRUITING

University of Colorado Anschutz, Aurora

All Listed Sponsors
collaborator

Colorado State University

OTHER

lead

University of Colorado, Denver

OTHER